Production (Stage)
COSCIENS Biopharma Inc.
CSCI
$3.68
$0.113.08%
NASDAQ
| 03/31/2025 | 12/31/2024 | 06/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.66M | -6.73M | -1.42M | -1.42M | -1.40M |
| Total Depreciation and Amortization | 325.00K | 392.00K | 377.00K | 377.00K | 359.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 123.00K | 2.59M | -2.16M | -2.16M | -377.00K |
| Change in Net Operating Assets | 1.33M | 754.00K | 1.82M | 1.82M | -961.00K |
| Cash from Operations | -1.88M | -3.00M | -1.39M | -1.39M | -2.38M |
| Capital Expenditure | -615.00K | -309.00K | -157.00K | -157.00K | -564.00K |
| Sale of Property, Plant, and Equipment | 4.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 26.04M | 26.04M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.00K | -7.00K | -- | -- | -- |
| Cash from Investing | -615.00K | -316.00K | 25.88M | 25.88M | -564.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -200.00K | -109.00K | -126.00K | -126.00K | -94.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -93.00K | -- | -- | -- |
| Cash from Financing | -200.00K | -202.00K | -126.00K | -126.00K | -94.00K |
| Foreign Exchange rate Adjustments | 60.00K | -88.00K | -67.00K | -67.00K | -134.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.64M | -3.61M | 24.30M | 24.30M | -3.17M |